FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...
Cystic fibrosis drug developer Sionna rises on trading debut
Sionna Therapeutics (NASDAQ:SION), a clinical-stage biopharma focused on developing cystic fibrosis therapies, opened well above its initial public offering price on Friday in its first trading ...
Dell issues five-day return-to-office mandate for employees, affecting thousands of Massachusetts-based workers, report says
The computer firm’s hybrid and remote workers — including those based out of the Hopkinton and Franklin offices — are expected to return to the office for five days a week next month, according to a ...
3 questions for Josh Kraft
HAPPY BIRTHDAY — to David Edelman, Ropes & Gray’s Abby Cable; former Gov. Charlie Baker senior adviser and the NCAA’s Tim ...
Vertex Pharmaceuticals (VRTX) Gets a Buy from J.P. Morgan
In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...
Vertex Pharmaceuticals (VRTX) Set for Painless Gains After FDA Approval
Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...
South Boston Online1d
Important New VERTEX Painkiller Is Approved
By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...
The Motley Fool6d
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...
STAT5d
The first shot taken at Medicaid, and Optum’s wellness visit ad
UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...
Record-high vacancies aren't stopping construction of new office buildings
The Boston area began 2025 with a record-high office vacancy rate of 17%. Yet there are at least seven notable office ...
New York IT firm cb20 expands to Boston
IT firm cb20 is expanding its services and reach into Boston. The Saratoga Springs, New York company is planning an office there later this year, Chris Pickett, president and CEO, said.
The Boston Globe5d
Boston tourism officials working on attracting nonstop flights to and from India
Greater Boston’s higher ed, pharmaceutical, and high-tech sectors all attract interest from India, Sheridan noted, and Massachusetts has a substantial Indian population. Sheridan said Meet ...